#therapeutics
#therapeutics

[ follow ]

Munich's mbiomics closes 30M to develop live bacterial product

mbiomics GmbH is developing a live bacterial product to enhance immune checkpoint inhibitor response in melanoma, with a Phase 1B study planned for 2027.

Medicine

fromNews Center

1 week ago

Visionary Biochemist Delivers 2026 Kimberly Prize Lecture - News Center

Svetlana Mojsov's research on GLP-1 transformed diabetes and obesity treatment, leading to widely prescribed therapies.

fromwww.ocregister.com

8 months ago

With UC Irvine and other programs, psychedelics soon could be as controversial as aspirin

UC Irvine’s Sue and Bill Gross School of Nursing is one of two California schools planning to teach future mental health nurses how psychedelics can be used to treat mental health issues.

Mental health

Health

fromwww.nature.com

9 months ago

How short peptides disassemble tau fibrils in Alzheimer's disease

D-peptide D-TLKIVWC may disassemble tau fibrils, suggesting a strategy to halt Alzheimer's disease progression.

fromwww.theguardian.com

10 months ago

UK scientists to synthesise human genome to learn more about how DNA works

The Synthetic Human Genome project aims to build human genetic material from scratch over the next five years to advance medical therapies by understanding DNA better.

Artificial intelligence

fromNature

1 year ago

Lung signals drive cancer-associated blood clots

Recent research has identified small extracellular vesicles (sEVs) released by the lungs as a source of pro-clotting signals in cancer patients, suggesting a predictive method for clot risk.

Cancer

[ Load more ]